A detailed history of High Point Advisor Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, High Point Advisor Group LLC holds 18,507 shares of NVO stock, worth $1.57 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
18,507
Previous 18,773 1.42%
Holding current value
$1.57 Million
Previous $2.68 Million 17.77%
% of portfolio
0.13%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $31,672 - $38,681
-266 Reduced 1.42%
18,507 $2.2 Million
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $36,444 - $43,632
297 Added 1.61%
18,773 $2.68 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $35,330 - $47,028
346 Added 1.91%
18,476 $2.37 Million
Q4 2023

Mar 26, 2024

BUY
$87.78 - $105.45 $1.59 Million - $1.91 Million
18,130 New
18,130 $1.88 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.